Insulin-like growth factor II and colorectal cancer risk in women

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 9, 2002, Pages 901-905

  Hunt, Kelly J ^a,d   Toniolo, Paolo ^b   Akhmedkhanov, Arslan ^b   Lukanova, Annekatrin ^a   Dechaud, Henri ^c   Rinaldi, Sabina ^a   Zeleniuch Jacquotte, Anne ^b   Shore, Roy E ^b   Riboli, Elio ^a   Kaaks, Rudolf ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Hopital de l'Antiquaille   (France)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY MASS; CANCER GROWTH; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; GENOME IMPRINTING; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036718861     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
2. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses’ Health Study
3. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
4. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
5. Insulin-like growth factors and their binding proteins: Biological actions
6. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
7. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice
8. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
9. An antibody that blocks insulin-like growth factor (IGF) binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts
10. The receptor for insulin-like growth factor II mediates an insulin-like response
11. Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate
12. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability
13. Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms’ tumour and gigantism
14. Beck-Wiedemann syndrome and Wilms’ tumour
15. Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes
16. Insulin-like growth factor II in two human colon-carcinoma cell lines: Gene structure and expression, and protein secretion
17. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: Role of IGF-II
18. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas
19. Insulin-like growth factors and their binding proteins in human colonocytes: Preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers
20. Abnormal expression and structural modification of the insulin-like growth-factor II gene in human colorectal tumors
21. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: Correlation with tumor progression, proliferative activity and survival
22. Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma
23. Circulating insulin-like growth factor II and colorectal adenomas
24. Alterations in serum levels of insulin-like growth factors and insulin-like growth factor-binding proteins in patients with colorectal cancer
25. IGF-I IGF-II in relation to colorectal cancer